Report identifies considerations for alternative payment models for cancer care (U.S.) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Monday, April 18, 2016

Report identifies considerations for alternative payment models for cancer care (U.S.)

medical news (U.S.)

...In July 2015, the Turning the Tide Against Cancer initiative convened a roundtable to discuss the effects of APMs on oncology innovation and patient care. The participants included physicians, researchers, advocates, representatives of insurers and pharmaceutical companies, and policymakers. The group identified five issues for the future design and implementation of APMs:
  • APMs should keep pace with rapidly emerging science by incentivizing the adoption of innovative medicines and technologies that have the potential to improve patient outcomes and make health care more efficient.
  • APMs should include mechanisms to encourage patient participation as appropriate in clinical trials as well as ongoing post-market clinical research.
  • Clinical pathways should be transparent and evidence-based, and updated regularly to reflect current scientific evidence and clinical advances within the overall continuum of care.
  • When providers and patients are making treatment decisions, patients should be given a clear, comprehensive picture of their treatment options, including cost information that is tailored to the specific patient's insurance coverage and treatment plan.
  • APMs should require that clinical data be aggregated and integrated into providers' workflows via electronic health records in order to support learning health care systems. Providers should have access to data that will support their shared decision-making with patients. Similarly, patients should have access to research results collected through a learning health care system.
These recommendations will be discussed in greater detail at the Annual Meeting 2016 session....

Turning the Tide Against Cancer Through Sustained Medical Innovation: The Pathway to Progress, Amy Abernethy, Edward Abrahams, Anna Barker, Ken Buetow, Randy Burkholder, William S. Dalton, Margaret Foti, Felix Frueh, Richard B. Gaynor, Marcia Kean, Zeba Khan, Tracy Lessor, J. Leonard Lichtenfeld, John Mendelsohn, and Laura van't Veer, Clinical Cancer Research, doi: 10.1158/1078-0432.CCR-13-3430, published online 12 February 2016.
Source: American Association for Cancer Research (AACR)


Post a Comment

Your comments?